believ best posit among peer group near long term n-
expect strong posit continu fuel growth overal market
penetr continu increas l-t believ optum particularli optuminsight
repres competit advantag think provid meaning first-mov
advantag market shift value-bas care
like market believ optum big differenti
compani benefit growth uhc drive volum optumrx
optuminsight technolog solut help lower medic cost uhc compani
continu increasingli benefit optum capabl uhc volum view
propos ci-esrx cvs-aet merger attempt replic mutual benefici
relationship uhc optum valid long-term vision
payment model increasingli shift toward value-bas reimburs believ
like better posit competitor long-term strateg point view
competitor pursu larg deal like close asset gap rel quickli
howev believ sever year oper collabor
uhc optum expect optum continu outpac growth uhc project
optum oper earn grow y/i y/i vs
uhc oper earn note project incorpor
impact davita medic group transact still pend ex-davita expect
modest margin expans across optum sub-seg next year aggreg optum
oper margin grow bp y/i vs expect approxim flat
margin uhc
much recent attent optum focus optumrx rebat
optumhealth provid acquisit believ signific technolog
asset includ optuminsight consumer-fac tool within uhc ex ralli
improv patient outcom lower cost tend overlook investor
believ unh technolog capabl connect tissu enabl
coordin care unh payor pbm provid asset
compani boast capabl believ ahead competitor term
integr medic pharmaci data gener valuabl insight deliv
inform back hand care provid
establish ep estim respect
establish price target base five-year dcf analysi impli
slightli greater price-to-earnings multipl ep estim
ep project line consensu believ impli equiti valu
conserv excess cash calcul cash less total debt contempl parent
compani cash conserv way calcul excess cash price
target impli upsid vs current level
pleas see page report import disclosur
posit share believ compani domin market share
health plan busi first-mov advantag close integr
healthcar servic busi provid compani competit advantag rel
peer group expect continu grow least line market
health plan busi potenti exceed industri averag growth rate
notabl medicar advantag howev believ real growth stori lie within
compani optum segment optum grown aggreg oper earn
approxim accord project level integr
uhc optum enabl compani succeed payment model
close davita medic group
expect year-end
medicar advantag enrol
repres
commerci ex-hif better
expect
medicaid ex-hif better
better expect growth medicaid
medicaid ex-hif membership
unitedhealth group incorpor diversifi health well-b compani
oper two segment unitedhealthcar uhc includ unitedhealthcar
commun state unitedhealthcar intern optum includ
optumhealth optuminsight optumrx
initi coverag outperform rate price target
believ compani domin market share health plan busi first-
mover advantag close integr healthcar servic busi provid
compani competit advantag rel peer group agre
larg consensu view increas level coordin uhc optum
enabl compani succeed payment model increasingli shift
toward value-bas care believ effect care coordin enhanc
combin pharmaci medic data believ capabl
one roof better align incent drive lowest net cost
note oper health plan pbm separ lead differ incent
recent confer call host one expert note formulari choic
differ stand-alone part plan ma-pd plan part d-onli formulari
design maxim rebat drive lowest drug spend ma-pd formulari
design minim net healthcar cost could mean allow higher drug
spend move toward value-bas care attempt lower net healthcar cost
would argu valu pbm increas intern health
plan note isnt necessarili lost market given premium valuat
afford part intern pbm capabl optumrx
unh competitor begun assembl asset enabl pursu
integr care model say goe rome wasnt built day optum
product year invest complementari supplementari
acquisit believ sever year ahead industri realiz
potenti benefit expand healthcar servic asset tightli
integr tradit health plan busi like direct
unh competitor move also deliv coordin care like take
sever year match degre integr optum
much optumrx uhc provid compani near-term
competit advantag cvs-aet ci-esrx merger still pend antm
ingeniorx doesnt go live januari
perhap importantli view believ easili overlook
technolog asset compani acquir and/or develop enabl optum
uhc oper collabor optuminsight major revenu earn driver
estim contribut roughli ep project
believ technolog asset essenti achiev compani long-term vision
strong technolog infrastructur abl analyz larg data set deliv
meaning action insight patient payer provid key improv
care coordin better manag healthcar cost competitor
data analyt system believ scale
unh unh earli invest acquisit optum give compani strong
head start view competitor get start gate
expect optum remain strong growth driver go forward project
continu double-digit oper earn growth across three optum sub-seg
modest bp margin expans note project
contempl potenti addit davita medic group dmg expect
close end expect dmg meaning near-term earn
contributor busi perform poorli recent year even assum
return better oper margin estim dmg would repres less
optumhealth oper earn expect optumcar sit within
optumhealth sub-seg continu one compani top invest
prioriti beyond
neglect remain posit outlook unh core health plan
busi particular top market share among insur medicar
advantag biggest growth opportun manag care expect uhc like
continu exceed industri averag growth rate medicar advantag
repres higher revenu higher margin opportun rel
govern busi project medicar advantag enrol growth
vs industri averag growth rate model assum bp increas
medicar advantag account above-averag growth howev
view assumpt conserv believ compani use benefit
hif-holiday improv margin and/or enhanc benefit drive addit growth
come bp better expect bp increas y/i
would repres upsid ep project uhc also larg
medicaid presenc see addit opportun grow space state
continu move complex popul ff manag care
commerci market expect uhc least maintain take share
shrink fulli insur space furthermor compani larg footprint posit
well captur custom transit fulli insur self-fund arrang
much recent attent optum focus optumrx rebat
optumhealth physician acquisit believ signific technolog
asset includ optuminsight consumer-fac tool within optumhealth
improv patient outcom lower cost gener overlook
investor made argument import integr medic
pharmaci benefits/data especi wake cvs-aet ci-esrx
merger howev mere own asset enough compani must abl
combin analyz data order gener meaning insight believ
unh technolog capabl connect tissu enabl coordin
care unh payor pbm provid asset
optuminsight start focus four market vertic health plan deliveri system
biotech life scienc compani govern state feder optuminsight
revenu mix evenli split payer provid govern
biotech/lif scienc compani make balanc differ optuminsight
technolog payer electron medic record agnost enabl physician
obtain complet view patient provid abl identifi at-risk
patient well identifi close gap care optuminsight foundat support
uhc via trend forecast popul health manag segment risk
model tool help uhc payer provid access best care best
provid close gap work uhc three-way collabor provid
data analyt tool within optuminsight fuel value-bas contract uhc
optumcar
equal import unh consumer-fac technolog solut hous
optumhealth visibl exampl ralli unh person
interact health well platform design help member make healthier
choic build better habit ralli three consum face platform
ralli choic help select manag benefit provid inform guid
individu choic push notif best
ralli engag make improv health easier help user understand
risk factor recommend small manag chang help prevent major
medic problem use gamif tool motiv user includ
competit reward
ralli connect transpar tool direct individu care base
price/ne compar pocket cost copay choos provid
read review
believ often skeptic come consumer-direct
technolog solut given percept engag consum difficult
agre consist engag consum isnt easi achiev
appear gain traction ralli connect user sinc launch
octob peopl use ralli earn billion health-rel
incent reward ralli nearli million weekli user set goal weight loss
stress reduct prevent care quit smoke
lastli note uhc exclus access new optum innov period
time offer broadli market think capabl
obviou revenu earn driver make uhc-optum stand apart
competitor
catalyst mileston watch
earn import quarter year manag care
compani complet claim inform accur assess
cost trend reserv level believ share pressur
earn due small miss lower level favor prior period
develop howev believ issu attribut tough comp
compani benefit year ago favor true-up part exit
individu busi rather indic rise medic cost trend
recent survey employ expect medic pharmaci cost
trend next year survey result suggest employ expect cost trend
rel stabl posit manag care group howev note
medic cost trend mute past year uptick
underli medic cost trend may difficult predict product price within
commerci medicar market
believ compani larg commerci individual/smal group medicar
advantag book like biggest beneficiari hif-holiday
medicar advantag believ insur use hif-holiday improv margin
and/or enhanc benefit drive addit growth major individu
group medicar advantag enrol growth come annual enrol
period octob decemb januari effect date
begin sens compani perform releas
monthli medicar advantag enrol report mid-januari februari
much focu around rebat center pharma suppli chain
compani pbm distributor fair note oper third largest
pbm optumrx countri estim share base claim
action taken trump administr could impact optumrx mid-
juli hh sent regul offic manag budget omb entitl
remov harbor protect rebat plan pbm involv prescript
pharmaceut creation new harbor protect market
gener interpret mean remov rebat medicar part
eventu commerci market well believ expect chang
occur dont believ wholesal chang current system like even
major chang would expect time year give
compani time adjust note alreadi implement pos
rebat one way help provid relief patient face rise out-of-pocket
optum announc acquisit davita medic group dmg decemb
indic expect deal close end acquisit
current undergo regulatori review expect deal ultim go
dmg segment underperform current ownership
believ optum manag team underwrit oper experi
improv perform busi unclear much detail compani
provid dmg transact close compani disclos
perform variou busi within optum sub-seg believ
acquisit materi impact ep given rel small size
busi compar overal enterpris curiou see
compani improv dmg oper perform addit dmg grow
optum owned/affili physician base approxim note
expand optumcar integr compon unh long-term strategi
price valu stock
initi price target base five-year discount cash flow
analysi establish ep estim
respect price target impli price-to-earnings multipl adjust ep
project suggest upsid current level trade
premium rel rest group believ premium deserv given
compani scale health plan busi rel advantag vs competitor
term integr medic pharmaci benefit move toward value-
use five-year discount cash flow analysi primari valuat method
deriv price target assum discount rate may appli
appropri adjust depend compani and/or industri specif factor
termin growth rate believ discount rate assumpt could view
conserv rel actual weight averag cost capit view
assumpt reason long run addit believ impli
equiti valu dcf could prove conserv excess cash calcul cash
less total debt contempl parent compani cash conserv
way calcul excess cash secondari measur look forward price-to-earnings
multipl impli dcf analysi compar histor averag
bear case risk call
medic cost trend mute past year uptick
underli medic cost may difficult predict product price within
commerci medicar market
becom largest employ owned/affili physician countri via
acquisit partnership optumhealth sub-seg pursu
integr care deliveri model optumhealth sub-seg
includ provid partnership ownership past align incent
particularli rise trend declin payment environ proven difficult
furthermor initi result optumcar shown promis certain
market unclear whether strategi scalabl success lower
cost long term unabl appropri align incent encourag
provid take risk patient popul compani determin
strategi costli gener suffici roi risk stuck
larg number capit intens asset may difficult divest
million except per-shar data
cowen compani estim
model assumptionstermin growth tax depreci chang work terminal- capit valuefre pv npv free npv futur excess valu total number valu per year end decemb cowen
million except per-shar data
compani report cowen compani
oper loss ratio chang y/ycost product oper tax rate tax earn attribut non-controlling incom common amort expens share outstand fulli net chang year-over-year oper incom common end decemb cowen
million except per-shar data
compani report cowen compani
oper loss ratio loss ratio product product oper revenue oper oper revenue ebitda oper tax rate tax earn attribut non-controlling incom common adjust intang amort expens effect intang amort share outstand fulli net chang year-over-yearpremium revenu cowen
million
compani report cowen compani
asset receiv incom tax current equip net acquir intang asset liabilitiesmed cost payabl accru polici paper current debt less current non-controlling equitycommon stock issu paid-in comp non-controlling sharehold liab liquid ratio current sale claim payabl premium premium structur long-term solvenc ratio return invest capit averag total asset averag stockhold equiti end decemb cowen
million
compani report cowen compani
 incom tax compens chang oper item account cost payabl polici flow oper secur paid acquisit net cash equip capit common stock issuanc foreign currenc rate chang cash cash increas decreas end decemb cowen
million
compani report cowen compani
 incom tax compens chang oper item account cost payabl polici oper paid acquisit net cash equip capit invest common stock long-term proce commerci paper issuanc long-term fund financ foreign currenc rate chang cash cash increas decreas end decemb cowen
valu manag care stock use pe multipl forward earn manag care
sector trade averag forward year earn past year
peak trough troubl econom time
frame given reform-rel multi-year top-lin growth prospect believ sector
trade high end recent histor valuat
success individu public exchang remain consider question mark
head third year program final year two three premium
stabil program reinsur risk corridor although exchang profit
expect improv expect continu money lose enterpris
industri particip receipt risk corridor payment remain potenti threat
success compani reli receiv medicar advantag payment
reduct includ potenti introduct new risk adjust model could
reduc futur medicar advantag margin growth prospect rel expect
gener medicaid payment expans popul gener
howev mount evid state like reduc payment level
medic cost trend mute past year uptick underli
medic cost may difficult predict product price within commerci
becom largest employ owned/affili physician countri via
acquisit partnership optumhealth sub-seg pursu
integr care deliveri model optumhealth sub-seg includ
provid partnership ownership past align incent particularli rise
trend declin payment environ proven difficult furthermor initi
result optumcar shown promis certain market unclear whether
strategi scalabl success lower cost long term unabl
appropri align incent encourag provid take risk patient
popul compani determin strategi costli gener
suffici roi risk stuck larg number capit intens asset may
difficult divest
